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MinireviewCD1 Trafficking: Invariant Chain
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natural functions of CD1-restricted T cells. T cell activa-
tion by exogenous bacterial antigens such as mycolyl
glycolipids that are taken up into the endosomal path-
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and Harvard Medical School ways of dendritic cells is consistent with the proposed
function of CD1 in host defense against infection (Por-Smith Building Room 514
1 Jimmy Fund Way celli and Modlin, 1999). On the other hand, presentation
of self-sphingolipids such as gangliosides or ceramidesBoston, Massachusetts 02115
2 Department of Microbiology and Immunology have been proposed to function in surveillance for tu-
mors, autoimmunity, and immunoregulatory interactionsAlbert Einstein College of Medicine
Room 416 Forchheimer Building among immune cells (Kawano et al., 1997; Shamshiev
et al., 2000; Godfrey et al., 2000). T cell stimulation by1300 Morris Park Avenue
Bronx, New York 10461 several of these known CD1-presented glycolipids has
been examined in detail, and these studies have led to
a simple molecular model for the presentation of glyco-
lipid antigens that is overall strongly analogous to T cellThe CD1 family of MHC class I-related proteins present
foreign and self-lipid antigens for specific recognition recognition of MHC/peptide complexes (Moody et al.,
1997; Burdin et al., 2000). Thus, the markedly amphi-by T cells. Based on previous experience with MHC
class I and II molecules, it seems likely that a thorough pathic glycolipid antigens are believed to bind to CD1
proteins by insertion of their alkyl tails into a hydropho-knowledge of the intracellular trafficking and localiza-
tion of CD1 proteins will be essential to fully under- bic groove in the CD1 heavy chain, forming a lipid/pro-
tein complex in which the carbohydrate portion of thestand their functions in antigen presentation and im-
mune responses. Two studies in this issue of Immunity antigen is exposed for direct contact with the TCRs of
specific T cells.take a detailed look at factors affecting the localization
of mouse CD1 proteins to the endocytic system of
antigen-presenting cells. Their results provide intrigu- Endosomal Localization of CD1 Proteins
ing evidence for the involvement of two critical compo- Peptide antigen-presenting molecules are faced with
nents of the MHC class II endosomal processing path- the daunting task of efficiently binding and displaying
way, cathepsin S and the invariant chain, in the normal those peptides that are relevant to immunity against an
functioning of CD1. infectious agent when these may be relatively scarce
and swimming in a sea of irrelevant self-peptides. Part
CD1 Proteins Bind and Present Lipid and Glycolipid of the solution to this problem has been the evolution
Antigens to T Cells of mechanisms for efficient peptide loading that act on
The discovery of antigen presentation by CD1 revealed MHC class I and II molecules within specific compart-
a previously unknown function for T cells, which is the ments of the cell that contain immunologically relevant
ability to recognize alterations in the lipid and glycolipid peptides. In the case of MHC class I, this compartment
content of cells that occurs in response to infection and is the endoplasmic reticulum, where endogenous self-
other disruptions of homeostasis. In most mammals, and viral peptides are acquired early in the assembly
multiple isoforms of CD1 proteins are expressed. In hu- of nascent class I complexes through a process that
mans, the CD1 family consists of five isoforms known involves specialized accessory proteins such as TAP
as CD1a, -b, -c, -d, and -e, and the first three of these and taposin (Cresswell, 2000). For MHC class II mole-
are known to function in T cell responses to naturally cules, the prime site for exogenous peptide loading is
occurring self- and foreign antigens (Martin et al., 1986; a subset of compartments within the endocytic system.
Porcelli and Modlin, 1999). Mice express homologs of These compartments, often called MIICs for “MHC class
only one human CD1 isoform, CD1d. Although naturally II compartments,” overlap considerably with lysosomes
occurring self- or foreign antigens presented by CD1d and may represent the products of fusion between late
remain elusive, this CD1 molecule has been a focus of endosomes and lysosomes (Geuze, 1998). In this site,
intense interest because of its role in the selection and MHC class II molecules are most efficiently brought into
function of an unusual subset of T cells with potent proximity with antigenic peptides generated from endo-
immunoregulatory properties known as NK T cells (Ben- cytosed extracellular proteins and with specialized ac-
delac et al., 1997). cessory molecules such as HLA-DM that catalyze pep-
The currently identified target antigens of CD1-medi- tide loading. This allows MHC class II preferential access
ated T cell responses are mainly glycolipids, and can to microbial peptides from extracellular pathogens.
be classified as diacylglycerols, sphingolipids, polyiso- As presenting molecules for specific foreign or self-
prenoids, or mycolates (Figure 1). Individual glycolipid lipid ligands, CD1 molecules also face a difficult task of
antigens not only differ from one another in structure binding enough of the relevant lipid antigens without
but also differ in the physiological circumstances in becoming overwhelmed by the multitude of normal lip-
which they are produced, providing insights into the ids that make up cellular membranes. The solution to
this problem again appears to lie at least partly in the
regulation of glycolipid loading within discrete intracel-2 Correspondence: porcelli@aecom.yu.edu
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Figure 1. CD1-Presented Glycolipid Antigens
Human and murine CD1 proteins mediate specific T cell recognition of lipids and glycolipids, including mycolic acids, glycosylated mycolates,
diacylglycerols, sphingolipids, and polyisoprenols. These antigens have been derived from mammalian and microbial sources. T cell recognition
of these antigens is specific for the structure of the antigen and the indicated CD1 isoform.
lular compartments, combined with cellular mecha- the available data indicate that it also localizes to intra-
cellular compartments, most likely late endosomes/ly-nisms that control the trafficking of CD1 proteins to
these compartments where loading of relevant lipid li- sosomes (Angenieux et al., 2000). The concentration
of different forms of CD1 to distinct and only partiallygands is favored. The first studies in this area focused
on the human CD1b protein, which is known for its ability overlapping endosomal compartments has led to the
hypothesis that the different isoforms are specialized toto present bacterial lipid antigens to T cells. The presen-
tation of such lipid antigens was found to be strongly present lipid ligands that accumulate within different
compartments of the cell.inhibited by drugs such as chloroquine and concana-
mycin A, which neutralize the pH of normally acidified
endosomes (Porcelli et al., 1992; Sieling et al., 1995). Cytoplasmic Tail-Mediated Trafficking
of CD1 MoleculesThis suggestion that lipid antigen loading onto CD1b
may occur predominantly in endosomal compartments The key factor accounting for the prominent accumula-
tion of most CD1 molecules in endosomal compart-was further supported by studies using immunofluo-
resence and immunoelectron microscopy, showing a ments has been shown to be the cytoplasmic tail se-
quences of these proteins. As shown first for humanprominent endocytic distribution of CD1b in dendritic
cells and a variety of transfected cell lines (Sugita et al., CD1b and then subsequently extended to other CD1
proteins including mouse CD1d, a tyrosine-based motif1996; Prigozy et al., 1997). In fact, CD1b could be found
prominently in the same MIIC compartments that con- corresponding to the sequence YXXφ (Y is tyrosine, X
is any amino acid, and φ is a residue with a bulky hy-tain much of the intracellular MHC class II molecules
that are undergoing peptide loading. drophic side chain) in the short cytoplasmic tail of CD1
proteins is sufficient to account for the bulk of theirSubsequent studies confirmed a similar theme for
most other CD1 molecules, with subtle but potentially steady state accumulation in endosomes (Sugita et al.,
1996; Jackman et al., 1998; Chiu et al., 1999). Suchimportant variations. Thus, the mouse CD1d protein,
a clear homolog in both structure and immunological tyrosine-based motifs are well known to interact with a
small group of cytosolic adaptor protein (AP) complexesfunction of human CD1d, was shown to localize strongly
to Lamp-1 compartments consistent with late endo- that play a crucial role in many intracellular protein sort-
ing events (Robinson and Bonifacino, 2001). Among thesomes or lysosomes (Chiu et al., 1999). However, careful
studies of other CD1 isoforms expressed by humans, four known AP complexes in mammalian cells, two of
these (AP-1 and AP-2) have been extensively studiedincluding CD1a, CD1c, and CD1e, revealed a unique
distribution for each of these. While CD1a was mainly for their role in the sorting of membrane proteins into
the endosomal network. Thus, AP-1, which is locatedlocated on the cell surface, it could also be found within
early recycling endosomes (Sugita et al., 1999; Schaible primarily at the cytoplasmic face of the trans-Golgi net-
work (TGN), has been implicated in sorting proteins suchet al., 2000). CD1c could be found within a range of
endosomal compartments, but imaging studies and as Lamp-1 from this site into the endocytic system. In
contrast, AP-2 localizes mainly to the plasma membranesubcellular fractionation indicated that it was promi-
nently shifted toward early endosomes while retaining and is required for the internalization of proteins from
this site into clathrin coated pits and vesicles, leadinglow expression in the late endosomes/lysosomes that
are the predominant site of CD1b accumulation (Schai- to entry into the endocytic pathway.
Since the deletion of the cytoplasmic tails of CD1ble et al., 2000; Briken et al., 2000). The recently identi-
fied CD1e protein is the least well-studied isoform, but molecules has generally been associated with a pro-
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found loss of their intracellular accumulation and redis- cell, thus implying that these associate in vivo. In a
series of transfection experiments, they found that whiletribution to the cell surface, the interactions of the YXXφ
motifs in these tails with AP-1 or AP-2 have been pre- removal of the cytoplasmic tail of CD1d causes a marked
redistribution to the cell surface, this can be partiallysumed to be a key step in the endosomal sorting of these
proteins. However, no studies had addressed which of reversed by coexpression of Ii. In this situation, Ii ap-
pears to direct CD1d to intracellular compartments thatthese AP complexes were likely to be responsible for
the sorting of CD1 proteins or what precise route was largely overlap with Lamp-1 late endosomes/lyso-
somes. Furthermore, in the absence of Ii (ie., B cells andtraveled by these proteins to reach their ultimate point
of accumulation in the endocytic network. These issues dendritic cells from Ii/ mice), they observed redistribu-
tion of a significant fraction of CD1d to the cell surface.are experimentally addressed for the first time by a study
in this issue of Immunity (Jayawardena-Wolf et al., 2001), This was associated with a failure of such Ii/ APCs to
optimally stimulate a subset of autoreactive NK T cellin which the authors use an extensive series of biochemi-
cal analyses to investigate the pathways taken by the hybridomas that has been suggested in previous studies
to respond to an endogenous CD1d-presented ligandmouse CD1d protein from its point of synthesis in the
ER to its ultimate point of accumulation in the late endo- that is dependent on endosomal loading (Chiu et al.,
1999). Such findings point to a significant effect of Ii insome/lysosome. Their studies show that while CD1d
ends up with a steady state distribution much like that modifying the antigen-presenting function of CD1d even
in the presence of an intact cytoplasmic tail targetingof MHC class II, the predominant route taken by these
two antigen-presenting molecules to the MIIC is proba- signal.
Although less direct in its approach, the study bybly different (Figure 2). Thus, while the majority of MHC
class II molecules are believed to be directed from the Riese et al. (2001) also implies an important link between
Ii and the functioning of CD1d in NK T cell activationTGN to the MIIC by virtue of the modified dileucine-
type targeting signals present in the associated class II and development. While evaluating the phenotype of
mice deficient in the endosomal protease cathepsin Sinvariant chain (Ii) (Watts, 2001), most CD1d appears to
take a more direct and rapid route to the cell surface (CatS), these authors made the surprising observation
that the numbers of CD1d-restricted NK T cells werefollowed by reinternalization to reach the MIIC. Since
AP-2 predominantly acts at the cell surface, this route significantly reduced in the organs of these mice. Since
CatS is known for its role in degrading Ii in the MIIC,to the MIIC points to AP-2-mediated sorting via interac-
tions with the cytoplasmic tail tyrosine-based motif as resulting in the exposure of the MHC class II peptide
binding site and the eventual release of MHC class IIa major determinant of endosomal localization of CD1d.
This movement of CD1d first to the outside of the cell molecules to the cell surface, their findings again sug-
gests some interplay between Ii and CD1d. Their resultsand then into its interior appears to be a major difference
between the way that these molecules access their anti- show abnormalities in the trafficking of CD1d, with more
accumulation of this protein in endosomes in associa-gen loading compartments compared to how this is usu-
ally achieved for MHC class II. While the functional sig- tion with the failure to completely degrade Ii and the
accumulation of a fragment of Ii (lip 10 Ii) in CatS/nificance of this unusual trafficking is not yet clear, one
hypothesis, depicted in Figure 2, is that trafficking to dendritic cells. In vitro studies also demonstrated de-
fects in the function of CD1d expressed by CatS/the cell surface leads to loading of a discrete set of
glycolipids in the secretory pathway, whereas recycling cells, including both a reduction in responses of CD1d
autoreactive T cell hybridomas and in the responses ofthrough the endosomal pathway results in exchange of
these antigens for others that are efficiently loaded onto freshly isolated NK T cells to the CD1d-presented lipid
antigen -galactosyl ceramide. This translates into aCD1d only in endosomal compartments. Thus, CD1d
proteins may be capable of repeated sampling of the significant defect in CD1d function in vivo, resulting in
a failure to normally select or expand the population ofvarious endosomal compartments as they they transit
back and forth between the plasma membrane and the CD1d-dependent NK T cells. Since at least some CD1d
molecules appear to associate with Ii, these findingsMIIC. Consistent with this view, Jayawardena-Wolf et
al. also show that CD1d molecules are relatively long- raise the possibility that MHC II and CD1d antigen pre-
sentation pathways may regulate one another by com-lived proteins in the cell (half life 15 hr, compared to
3 hr for MHC class I), and that they undergo intensive petition for Ii sorting machinery. On the other hand, since
the CatS knockout may have more general effects lead-recycling between the plasma membrane and intracellu-
lar compartments. ing to reduced egress of proteins from late endosomal
compartments, it remains possible that CD1 and MHC
class II presentation both rely crucially on antigen pro-The Class II Invariant Chain in CD1 Trafficking
cessing events in MIIC but function independently.While the cytoplasmic tails of CD1 proteins seem to play
a dominant role in controlling recycling and determining
the overall steady state distribution of these proteins, Implications for the Role of CD1 in Immunity
The finding that Ii associates with CD1d and affectsevidence for another potentially significant factor in this
process comes from the study by Jayawardena-Wolf et its trafficking and its ability to engage specific T cell
receptors provides a further parallel between the CD1al. (2001) and from a second study by Riese et al. that
also appears in this issue of Immunity. Using a direct in system and the MHC class II family to which it is distantly
related in evolution. Thus, both CD1 and MHC class IIvitro approach, Jayawardena-Wolf et al. show that a
fraction of CD1d molecules are coprecipitated with Ii proteins frequently occupy the same intracellular com-
partments, notably the MIICs in the case of CD1b andwhen both of these molecules are expressed in the same
Immunity
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Figure 2. Endosomal Pathways for Presentation of Antigens by CD1 and MHC Class II
Key features of the trafficking of CD1d (left) and MHC class II (right) molecules to the MIIC are compared. In the case of MHC class II,
associated invariant chain (Ii) blocks the antigen binding groove and directs MHC II from the trans-golgi network (TGN) to MHC class II
compartments (MIIC). Here, cathepsin S (S) cleaves Ii, releasing the MHC class II associated invariant chain peptide (CLIP) and exposing the
groove for peptide exchange prior to release of MHC II to the cell surface (solid arrows). A second, less dominant pathway (dashed arrow)
into the endosomes for MHC class II involves recycling from the cell surface as a result of the dileucine motif in the cytoplasmic tail of the 
chain. In contrast, most CD1d proteins move rapidly to the cell surface and are subsequently delivered to MIICs by the internalization and
recycling pathway that is controlled by the cytoplasmic tail tyrosine-based motif and its interaction with clathrin adaptor protein complexes
(AP) (solid arrows). The two new studies in the current issue of Immunity suggest the possibility of a second pathway to the MIIC for CD1d
which is dependent on Ii and cathepsin S (dashed arrow).
CD1d. Both sets of molecules can efficiently present class II being mainly in the relative emphasis of the two
signals (Figure 2).exogenous ligands entering into the cell through endo-
cytosis. With the current findings in the two Immunity The discovery of this additional parallel between the
MHC class II system, the primary function of which ispapers, it is now apparent that both sets of molecules
can potentially use two distinct sets of signals to control clearly the stimulation of immune responses to infection,
and the CD1 system is further support for the hypothesistheir entry into the endocytic pathway. In the case of
CD1, the influence of the cytoplasmic YXXφmotif clearly that CD1 also serves mainly as a microbial recognition
system. In the case of mouse CD1d, this point is stillpredominates but may be significantly altered by the
addition of modified dileucine motifs provided by asso- considered open for debate as the evidence for presen-
tation of foreign microbial antigens by CD1d in theciated Ii chains. In the case of MHC class II, Ii is accepted
to be the principal signal regulating endocytic targeting, mouse system remains extremely scarce (Shinkai and
Locksley, 2000). Instead, what continues to accumulateyet it has also been shown that the cytoplasmic tail of
the MHC class II  chain contains a conserved dileucine are examples of the ability of CD1d-restricted NK T cells
to regulate responses of the adaptive immune system.motif that also can affect internalization from the plasma
membrane (Zhong et al., 1997). Thus, both families of This has been associated with the control of autoim-
mune inflammatory diseases in vivo, which is particularlyantigen-presenting molecules can be viewed as having
one signal that mainly specifies recycling (i.e., cyto- striking in the case of type I diabetes mellitus in the
NOD mouse model (Shi et al., 2001; Wang et al., 2001).plasmic tail motif) and one signal that targets more
deeply into the endocytic pathway (i.e., associated Ii How NK T cells might be activated in the absence of
infection to perform their immunoregulatory functionschain), with the difference between CD1d and MHC
Minireview
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Robinson, M.S., and Bonifacino, J.S. (2001). Curr. Opin. Cell Biol.remains unresolved. Conceivably, this may come about
13, 444–453.through the recognition of endogenous ligands, pre-
Schaible, U.E., Hagens, K., Fischer, K., Collins, H.L., and Kaufmann,sumed to be self-lipids or glycolipids bound to CD1d
S.H. (2000). J. Immunol. 164, 4843–4852.molecules (Joyce et al., 1998; Chiu et al., 1999). If so, it
Shamshiev, A., Donda, A., Prigozy, T.I., Mori, L., Chigorno, V., Bene-is extremely likely that the presentation of such ligands
dict, C.A., Kappos, L., Sonnino, S., Kronenberg, M., and de Libero,
will be to a great extent dependent on the intracellular G. (2000). Immunity 13, 255–264.
trafficking of CD1d. This also raises the possibility that
Shi, F.D., Flodstrom, M., Balasa, B., Kim, S.H., Van Gunst, K., Stro-
altered CD1d trafficking could contribute to the develop- minger, J.L., Wilson, S.B., and Sarvetnick, N. (2001). Proc. Natl.
ment of autoimmunity or the failure to regulate normal Acad. Sci. USA 98, 6777–6782.
immunity. Shinkai, K., and Locksley, R.M. (2000). J. Exp. Med. 191, 907–914.
It remains to be determined whether or to what extent Sieling, P.A., Chatterjee, D., Porcelli, S.A., Prigozy, T.I., Mazzaccaro,
other isoforms of CD1 will follow the rules that are now R.J., Soriano, T., Bloom, B.R., Brenner, M.B., Kronenberg, M., Bren-
nan, P.J., et al. (1995). Science 269, 227–230.being laid out for mouse CD1d. Evidence from in vitro
studies has supported a role in foreign lipid or glycolipid Sugita, M., Jackman, R.M., van Donselaar, E., Behar, S.M., Rogers,
R.A., Peters, P.J., Brenner, M.B., and Porcelli, S.A. (1996). Scienceantigen presentation leading to antimicrobial immunity
273, 349–352.for several human CD1 isoforms that are absent from
Sugita, M., Grant, E.P., van Donselaar, E., Hsu, V.W., Rogers, R.A.,the mouse (CD1a, CD1b, and CD1c). The potential thus
Peters, P.J., and Brenner, M.B. (1999). Immunity 11, 743–752.exists for in vitro studies to assess the role of Ii and
Wang, B., Geng, Y.B., and Wang, C.R. (2001). J. Exp. Med. 194,its affects on trafficking of these CD1 molecules in the
313–320.
presentation of defined microbial lipid ligands. Such
Watts, C. (2001). Curr. Opin. Immunol. 13, 26–31.studies could lead to further insights into the apparent
Zhong, G., Romagnoli, P., and Germain, R.N. (1997). J. Exp. Med.interplay between the CD1 presentation system and the
185, 429–438.
other arms of the adaptive immune response.
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